SCHEMBL335161

SCHEMBL335161

c1ccc2c(c1)CCO2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29373453 1.00
SCHEMBL33192 1.00
Methane SCHEMBL28208258 0.97 ITGB2 (0.55)
SCHEMBL9098245 0.97 ITGB2 (0.55)
Water SCHEMBL28018355 0.97 ITGB2 (0.55)
SCHEMBL28287702 0.97
SCHEMBL30335609 0.97 ITGB2 (0.55)
Hydrochloric Acid SCHEMBL11784012 0.95 ITGB2 (0.52)
Hydrochloric Acid SCHEMBL11794091 0.95 ITGB2 (0.52)
Hydrochloric Acid SCHEMBL11784501 0.95 ITGB2 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117466873-A Pyrimidine compound and application thereof in medicines 广东东阳光药业股份有限公司 2024-01-30 CN claimed
CN-117402185-A Triazine compound and application thereof in medicines 广东东阳光药业股份有限公司 2024-01-16 CN claimed
EP-2493877-B1 PYRIMIDINE COMPOUNDS AS DELTA OPIOID RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-09-17 EP claimed
US-20130310358-A1 PYRIMIDINE COMPOUNDS AS DELTA OPIOID RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2013-11-21 US claimed
US-8513271-B2 Pyrimidine compounds as delta opioid receptor modulators JANSSEN PHARMACEUTICA, NV (BE) 2013-08-20 US claimed
US-8106214-B2 2-imino-4-(thio) oxo-5-polycyclovinylazolines for use as PI3 kinase inhibitors MERCK SERONO SA (CH) 2012-01-31 US claimed
US-20110269759-A1 PYRIMIDINE COMPOUNDS AS DELTA OPIOID RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2011-11-03 US claimed
US-20110105520-A1 PYRIMIDINE COMPOUNDS AS DELTA OPIOID RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2011-05-05 US claimed
US-7732604-B2 Triazolopyrazine derivatives PFIZER INC. (US) 2010-06-08 US claimed
US-20100105656-A1 TRIAZOLOPYRAZINE DERIVATIVES PFIZER INC. 2010-04-29 US claimed
EP-1648452-B1 2-IMINO-4-(THIO)OXO-5-POLYCYCLOVINYLAZOLINES FOR USE AS PI3 KINASE INHIBITORS MERCK SERONO SA (CH) 2009-07-22 EP claimed
US-20080306057-A1 P13K Inhibitors for the Treatment of Endometriosis LABORATORIES SERONO SA (CH) 2008-12-11 US claimed
US-20070021447-A1 2-Imino-4-(thio)oxo-5-poly cyclovinylazolines for use as p13 kinase ihibitors APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2007-01-25 US claimed
JP-2007500171-A 2007-01-11 JP claimed
EP-1648452-A1 2-IMINO-4-(THIO)OXO-5-POLYCYCLOVINYLAZOLINES FOR USE AS PI3 KINASE INHIBITORS Applied Research Systems ARS Holding N.V. (AN) 2006-04-26 EP claimed
WO-2005011686-A1 2-IMINO-4-(THIO) OXO-5-POLY CYCLOVINYLAZOLINES FOR USE AS P13 KINASE IHIBITORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2005-02-10 WO claimed
US-12012373-B2 Cannabinoid derivatives CANOPY GROWTH CORPORATION (CA) 2024-06-18 US disclosed
EP-4090662-B1 PREPARATION OF BUPRENORPHINE RIVER STONE BIOTECH APS (DK) 2024-06-12 EP disclosed
US-20040138275-A1 Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION 2004-07-15 US disclosed
US-20040092561-A1 Azolidinone-vinyl fused -benzene derivatives APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2004-05-13 US disclosed